The adipocyte-specific hormone leptin, the product of the obese (ob) g
ene, regulates adipose-tissue mass through hypothalamic effects on sat
iety and energy expenditure(1-4), Leptin acts through the leptin recep
tor, a single-transmembrane-domain receptor of the cytokine-receptor f
amily(5-7). In rodents, homozygous mutations in genes encoding leptin(
1) or the leptin receptor(6) cause early-onset morbid obesity, hyperph
agia and reduced energy expenditure, These rodents also show hypercort
isolaemia, alterations in glucose homeostasis, dyslipidaemia, and infe
rtility due to hypogonadotropic hypogonadism(8). In humans. leptin def
iciency due to a mutation in the leptin gene is associated with early-
onset obesity(9), Here we describe a homozygous mutation in the human
leptin receptor gene that results in a truncated leptin receptor lacki
ng both the transmembrane and the intracellular domains, In addition t
o their early-onset morbid obesity, patients homozygous for this mutat
ion have no pubertal development and their secretion of growth hormone
and thyrotropin is reduced. These results indicate that leptin is an
important physiological regulator of several endocrine functions in hu
mans.